← Leaderboards
John H Stone
Johns Hopkins University
$4,927,318
Attributed
$4,927,318
Total exposure
20
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $479.9K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,927,318 · 20
By mechanism
P41$1,992,340 · 11
UM1$1,069,836 · 1
N01$828,621 · 1
K24$350,851 · 1
R01$222,177 · 1
U01$197,320 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Peter A Merkel$19,482,229
- Philip Seo$668,043
- Sabra L Klein$13,115,675
- John H. Kempen$14,361,889
- Antony Rosen$15,771,548
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingClinical ResearchResearch PersonnelProgramsComputersCellsPhenotypeClinical TrialsUnited States National Institutes Of HealthSamplingTemporal ArteritisSourceResourcesFunctional DisorderGrantMassachusettsGeneral HospitalsInstrumentPathologicRheumatologyFibrosisAutoimmune DiseasesFlareDose
Grant awards (35)
Targeting T cell Subsets in Autoimmune Disease$333,918
UM1 · FY2025 · AI · contact PI
Targeting T cell Subsets in Autoimmune Disease$333,918
UM1 · FY2024 · AI · contact PI
Targeting T cell Subsets in Autoimmune Disease$67,000
UM1 · FY2023 · AI · contact PI
Targeting T cell Subsets in Autoimmune Disease$67,000
UM1 · FY2022 · AI · contact PI
Targeting T cell Subsets in Autoimmune Disease$67,000
UM1 · FY2021 · AI · contact PI
Targeting T cell Subsets in Autoimmune Disease$67,000
UM1 · FY2020 · AI · contact PI
Targeting T cell Subsets in Autoimmune Disease$134,000
UM1 · FY2019 · AI · contact PI
VMD, A PROGRAM FOR MODEL BUILDING, STRUCTURE ANALYZING, AND SEQUENCE ANALYZING$149,202
P41 · FY2011 · RR · contact PI
PETASCALE MOLECULAR DYNAMICS DATA PROCESSING$66,312
P41 · FY2011 · RR · contact PI
ACCELERATION OF MOLECULAR MODELING APPLICATIONS WITH GRAPHICS PROCESSORS$33,156
P41 · FY2011 · RR · contact PI
The First International Symposium on IgG4-Related Systemic Disease$22,500
R13 · FY2011 · AR · contact PI
VMD, A PROGRAM FOR MODEL BUILDING, STRUCTURE ANALYZING, AND SEQUENCE ANALYZING$150,709
P41 · FY2010 · RR · contact PI
PETASCALE MOLECULAR DYNAMICS DATA PROCESSING$66,982
P41 · FY2010 · RR · contact PI
VMD, A PROGRAM FOR MODEL BUILDING, STRUCTURE ANALYZING, AND SEQUENCE ANALYZING$172,551
P41 · FY2009 · RR · contact PI
VMD, A PROGRAM FOR MODEL BUILDING, STRUCTURE ANALYZING, AND SEQUENCE ANALYZING$142,101
P41 · FY2008 · RR · contact PI
VMD$165,077
P41 · FY2007 · RR · contact PI
VMD$123,559
P41 · FY2006 · RR · contact PI
RAVE$34,586
M01 · FY2006 · RR · contact PI
Translational Research in Systemic Vasculitis$25,302
K24 · FY2006 · AR · contact PI
Vasculitis Outcome Measures: Development and Validation$197,320
U01 · FY2005 · AR
VMD HIGH PERFORMANCE, LOW COST MOLECULAR VISUALIZATION$159,107
P41 · FY2005 · RR
Translational Research in Systemic Vasculitis$123,511
K24 · FY2005 · AR
Vasculitis Outcome Measures: Development and Validation$222,177
R01 · FY2004 · AR
VMD HIGH PERFORMANCE, LOW COST MOLECULAR VISUALIZATION$202,215
P41 · FY2004 · RR
Translational Research in Systemic Vasculitis$120,700
K24 · FY2004 · AR
A Randomized, Double Blind, Placebo Controlled Study of Enbrel in the Treatm...$45,187
M01 · FY2004 · RR
Translational Research in Systemic Vasculitis$81,338
K24 · FY2003 · AR
MOLECULAR VISUALIZATION PROGRAM VMD$68,666
P41 · FY2002 · RR
MOLECULAR VISUALIZATION PROGRAM VMD$68,666
P41 · FY2002 · RR
MOLECULAR VISUALIZATION PROGRAM VMD$68,666
P41 · FY2001 · RR
MOLECULAR VISUALIZATION PROGRAM VMD$68,666
P41 · FY2001 · RR
RANDOMIZED CLINICAL TRIAL OF ETANERCEPT IN WEGENER'S$828,621
N01 · FY2000 · AR
MOLECULAR VISUALIZATION PROGRAM VMD$173,760
P41 · FY2000 · RR
GIANT CELL ARTERITIS AND BACTERIAL INFECTIONS$163,900
R21 · FY2000 · HL
MOLECULAR VISUALIZATION PROGRAM VMD$112,945
P41 · FY2000 · RR